Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Alonso

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
European Journal of Neurology|November 20, 2021
Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohortEdgar Carnero Contentti, Pablo A López, Juan Criniti, et al.
Multiple Sclerosis and Related Disorders|March 12, 2023
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin AmericaEdgar Carnero Contentti, Pablo A López, Juan Criniti, et al.
Multiple Sclerosis and Related Disorders|July 9, 2021
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemicAnibal Chertcoff, Johana Bauer, Berenice Anabel Silva, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Journal of Neurology|September 7, 2021
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEMJuan I Rojas, Agustín Pappolla, Patricio Blaya, et al.
Multiple Sclerosis and Related Disorders|August 27, 2023
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in ArgentinaRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)Ricardo Alonso, Cecilia Quarracino, Bárbara Eizaguirre, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Journal of the Neurological Sciences|June 19, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort studyEdgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi, et al.
European Journal of Neurology|November 20, 2021
Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohortEdgar Carnero Contentti, Pablo A López, Juan Criniti, et al.
Multiple Sclerosis and Related Disorders|March 12, 2023
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin AmericaEdgar Carnero Contentti, Pablo A López, Juan Criniti, et al.
Multiple Sclerosis and Related Disorders|July 9, 2021
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemicAnibal Chertcoff, Johana Bauer, Berenice Anabel Silva, et al.
Multiple Sclerosis and Related Disorders|July 21, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)Edgar Carnero Contentti, Pablo A Lopez, Liliana Patrucco, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Journal of Neurology|September 7, 2021
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEMJuan I Rojas, Agustín Pappolla, Patricio Blaya, et al.
Multiple Sclerosis and Related Disorders|August 27, 2023
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in ArgentinaRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 30, 2023
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in ArgentinaEdgar Carnero Contentti, Pablo A López, Agustín Pappolla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 26, 2020
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM)Ricardo Alonso, Cecilia Quarracino, Bárbara Eizaguirre, et al.
Pageof 16